CD4 and pneumocystosis: PJP was associated with a 20∼40% mortality rate in individuals with profound immunosuppression, particularly in patients with CD4+ T lymphocyte cell counts < 200 cells/mm, and lifelong PJP prophylaxis after lung transplantation is recommended by some experts [16].